The Indian Institute of Science has announced an online course on machine learning for 6G wireless communication under its Centre for Continuing Education (CCE). The programme is scheduled to run from ...

“Python’s Kiss” collects a baker’s dozen stories, nine of which previously have been published in the New Yorker and elsewhere (each is illustrated with a drawing by the author’s daughter, Aza Erdrich ...

The University of Houston System's general counsel defended the dual course reviews underway across UH campuses on Thursday, telling the Board of Regents that top administrators chose an approach that ...

Never miss a story with The Brief, our free newsletter. Independent Texas reporting needs your support. Help us bring you and millions of others in-depth news and information. Will you join our ...

The 2026 Mazda CX-50 reminds me of T.S. Eliot’s poem “Burnt Norton”: “What might have been and what has been/Point to one end, which is always present.” Because I’m classy. Introduced for model-year ...

The Dell XPS 14 brings the company’s flagship laptop back into competition with speedy Intel Core Series 3 chips and a redesign that’s more practical, yet still premium. In 2022, Dell took a big swing ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. The SE exam is a PE exam ...

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a ...